Toshiba America Medical Systems will contribute its Aplio CV ultrasound system to Johns Hopkins Bayview Medical Center's clinical study using ultrasound and CT to assess outcomes following cardiac resynchronization therapy (CRT).
The study will try to determine which echocardiography measurement or combination of measurements best predicts CT-determined reverse-remodeling in cardiac patients undergoing resynchronization therapy. It will also explore whether coronary venous anatomy predicts CT-determined reverse-remodeling in cardiac patients undergoing resynchronization therapy.
Aplio CV will be used for 30 months in conjunction with Toshiba's Aquilion 64 CFX 64-slice CT system.
By AuntMinnie.com staff writers
November 7, 2005
Related Reading
Toshiba America Medical Systems, November 4, 2005
Toshiba America Medical Systems, November 3, 2005
Toshiba launches breast MRI coil, November 3, 2005
Toshiba unwraps CF-i/SP, October 17, 2005
Toshiba notches 200th Vantage install, October 13, 2005
Copyright © 2005 AuntMinnie.com
